- MarketWatch•1 hour ago
Shares of PDL BioPharma Inc. were indicated up over 2% in premarket trade Monday, after the marketer of biopharmaceutical products said it will be paid a one-time lump sum of $19.5 million by Merck & Co. ...
- Business Wire•2 days ago
Merck Announces New Phase 2 Data on Investigational Triple Combination Therapy MK-3682B for Chronic Hepatitis C
Merck , known as MSD outside of the United States and Canada, today announced the first sustained virologic response1 results 12 weeks after completion of therapy from C-SURGE, an ongoing, open label Phase 2 clinical trial evaluating MK-3682B , the company’s investigational triple-combination therapy in treatment-experienced patients with hepatitis C virus genotype ...
- Associated Press•3 days ago
Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders.
MRK : Summary for Merck & Company, Inc. (new) - Yahoo Finance
Merck & Co., Inc. (MRK)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||61.87 - 62.63|
|52 Week Range||53.06 - 66.80|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||43.89|
|Dividend & Yield||1.88 (2.99%)|
|1y Target Est||N/A|